Krebs Biochemicals & Industries Limited

85.12

INR
-0.06(-0.07%)
As of November 14, 2024 10:00:00 AM

Krebs Biochemicals & Industries Limited Share Price Information

24 hour Low and High

Low: 83.11
High: 89.6

All time High

213.05

Price Change 1h

+₹-2.88 +-3.27%

Price Change 1d

+₹-2.88 +-3.27%

Price Change 1w

+₹-5.52 +-6.09%

Krebs Biochemicals & Industries Limited Market Information

Exchange

NSE

Market Cap

173.63 Cr

About Krebs Biochemicals & Industries Limited Share

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is based in Visakhapatnam, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

191

CEO

Mr. Jitendra Rameshchandra Shah

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Krebs Bio zooms ahead of Ipca Labs open offer
  • IPCA Labs to pick up 26% stake in Krebs Bio
  • Krebs Ltd. seeks nod to resume production at biochemical unit
  • Ipca Labs starts open offer for Krebs Biochemicals
  • Krebs Biochemicals has put public health at risk: HRF

FAQs

Krebs Biochemicals & Industries Limited

85.12

INR
-0.06(-0.07%)
As of November 14, 2024 10:00:00 AM

Krebs Biochemicals & Industries Limited Share Price Information

24 hour Low and High

Low: 83.11
High: 89.6

All time High

213.05

Price Change 1h

+₹-2.88 +-3.27%

Price Change 1d

+₹-2.88 +-3.27%

Price Change 1w

+₹-5.52 +-6.09%

Krebs Biochemicals & Industries Limited Market Information

Exchange

NSE

Market Cap

173.63 Cr

About Krebs Biochemicals & Industries Limited Share

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is based in Visakhapatnam, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

191

CEO

Mr. Jitendra Rameshchandra Shah

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Krebs Bio zooms ahead of Ipca Labs open offer
  • IPCA Labs to pick up 26% stake in Krebs Bio
  • Krebs Ltd. seeks nod to resume production at biochemical unit
  • Ipca Labs starts open offer for Krebs Biochemicals
  • Krebs Biochemicals has put public health at risk: HRF

FAQs